PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

NCT04870333 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

2240

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Niclosamide
DRUG: Placebo
DRUG: Ciclesonide
DRUG: Placebo
DRUG: Sotrovimab
DRUG: Placebo

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]